azacitidine
Showing 1 - 25 of 274
Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
- (no location specified)
Mar 15, 2023
Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)
Not yet recruiting
- Acute Kidney Disease
- Azacitidine
- Placebo
-
Taipei City, TaiwanYu Hsiang Chou
May 2, 2022
Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)
Not yet recruiting
- Higher Risk Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
- AMG 176
- Azacitidine
- (no location specified)
Jul 29, 2022
MDS Trial in Saint Louis (vosaroxin, Azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes
- vosaroxin
- Azacitidine
-
Saint Louis, MissouriWashington University School of Medicine
Mar 23, 2022
Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)
Not yet recruiting
- Leukemia, Myeloid, Acute
- Azacitidine
- Venetoclax
-
Guanzhou, Guandong, ChinaNanfang Hospital of Southern Medical University
Jul 22, 2022
Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia
- Relapsed Adult AML
- Lintuzumab-Ac225
- +2 more
- (no location specified)
Feb 22, 2022
High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)
Recruiting
- High Grade Myelodysplastic Syndromes
- Omacetaxine
- Azacitidine
-
Aurora, ColoradoUniverstiy of Colorado Denver
Oct 19, 2021
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- LP-108
- Azacitidine
- (no location specified)
Nov 29, 2022
Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- Venetoclax
-
Aurora, ColoradoUniverstiy of Colorado Hospital
Feb 15, 2022
Myeloid Malignancy Trial in Detroit (azacitidine)
Recruiting
- Myeloid Malignancy
- azacitidine
-
Detroit, MichiganHenry ford hospital
Dec 23, 2021
Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)
Recruiting
- Chronic Myeloid Leukemia
- Myelofibroses
- Azacitidine
- Selumetinib
-
Chicago, IllinoisThe University of Chicago
May 16, 2022
Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)
Not yet recruiting
- Advanced Systemic Mastocytosis
- BLU-263
- Azacitidine
- (no location specified)
Nov 2, 2022
Acute Myeloid Leukemia Trial in Sacramento (Azacitidine, Uproleselan, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Aug 12, 2022
Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)
Active, not recruiting
- Melanoma and Other Malignant Neoplasms of Skin
- Metastatic Melanoma
- Azacitidine
- Pembrolizumab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 28, 2022
Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life
Recruiting
- Secondary Myelodysplastic Syndrome
- Therapy-Related Myelodysplastic Syndrome
- Azacitidine
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 6, 2022
Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)
Recruiting
- Leukemia, Myeloid, Acute
- Azacitidine
- Chidamide
-
Guanzhou, Guandong, ChinaNanfang Hospital of Southern Medical University
Mar 6, 2022
Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,
Recruiting
- Philadelphia Chromosome
- +4 more
- Azacitidine
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jun 23, 2022
Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,
Not yet recruiting
- Acute Myeloid Leukemia
- +10 more
- Ziftomenib
- +4 more
- (no location specified)
Feb 17, 2023
Relapsed/Refractory Peripheral T-cell Lymphoma Trial in Suzhou (Anti-PD-1 mAb, Lenalidomide, Azacitidine)
Recruiting
- Relapsed/Refractory Peripheral T-cell Lymphoma
- Anti-PD-1 monoclonal antibody
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 21, 2021
Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)
Withdrawn
- Myelodysplastic Syndrome (MDS)
- FF-10501-01
- Azacitidine
- (no location specified)
Jul 20, 2021
Acute Myeloid Leukemia, AML, Adult Trial in United States (evorpacept, venetoclax, azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia
- AML, Adult
- evorpacept
- +2 more
-
Chicago, Illinois
- +4 more
Jun 7, 2022
Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)
Active, not recruiting
- Pancreas Cancer
- Pembrolizumab
- Azacitidine
-
New York, New YorkColumbia University Irving Medical Center
Oct 20, 2021
MDS Trial (Pevonedistat, Azacitidine)
No longer available
- Myelodysplastic Syndromes
- Pevonedistat
- Azacitidine
- (no location specified)
Sep 8, 2021